Calavo Growers Discloses Shareholder Lawsuits, Supplements Merger Proxy with Financial Advisor's Undervaluation Details

summarizeSummary

Calavo Growers has disclosed two shareholder lawsuits challenging its proposed merger with Mission Produce and voluntarily supplemented its proxy statement with updated financial analyses, including a discounted cash flow valuation that suggests the merger consideration is below the company's intrinsic value.

check_boxKey Events

• Shareholder Lawsuits Filed

  Two lawsuits were filed on March 26, 2026, in New York, challenging the merger with Mission Produce, alleging disclosure deficiencies and seeking injunctive relief, rescission, and damages.

• Proxy Statement Supplemented

  Calavo Growers voluntarily supplemented its Joint Proxy Statement/Prospectus to address the lawsuit allegations and provide additional information, without admitting culpability.

• Updated Financial Advisor Opinion

  The supplemental disclosures include revised financial analyses from Jefferies, Calavo's financial advisor, for the proposed merger with Mission Produce.

• DCF Analysis Shows Potential Undervaluation

  The updated Discounted Cash Flow analysis indicates an implied per share equity value range for Calavo of $33.65 to $41.80 (standalone) and $35.00 to $43.35 (pro forma combined company), which is substantially higher than the $27.00-$27.15 merger consideration.

auto_awesomeAnalysis

This filing is highly significant as it reveals new shareholder lawsuits challenging the proposed merger with Mission Produce, alleging disclosure deficiencies. More critically, the voluntary supplemental disclosures include updated financial analyses from Calavo's financial advisor, Jefferies. The revised Discounted Cash Flow (DCF) analysis now indicates an implied per share equity value range for Calavo of $33.65 to $41.80 on a standalone basis, and $35.00 to $43.35 for the pro forma combined company. These ranges are notably higher than the merger consideration of $27.00-$27.15 per share. This discrepancy could significantly influence shareholder voting on April 28, 2026, potentially leading to increased shareholder dissent, further legal challenges, or even a renegotiation of the merger terms. Investors should carefully review these updated valuations ahead of the vote.